Overcoming the Delivery Hurdle for Peptide Therapeutics: New Treatment for Autoimmune Diseases

Norton, Raymond (Primary Chief Investigator (PCI))
Beeton, Christine (Chief Investigator (CI))
Boyd, Benjamin (Chief Investigator (CI))
Nicolazzo, Joseph (Chief Investigator (CI))

Project: Research

Status	Finished
Effective start/end date	1/01/13 → 31/12/15

Funding

National Health and Medical Research Council (NHMRC) (Australia): A$232,593.63
National Health and Medical Research Council (NHMRC) (Australia): A$322,518.72

3 Article
1 Chapter (Book)
1 Review Article

Enhancing the therapeutic potential of peptide toxins
Norton, R. S., 3 Jun 2017, In: Expert Opinion on Drug Discovery. 12, 6, p. 611-623 13 p.
Research output: Contribution to journal › Review Article › Research › peer-review

43 Citations (Scopus)
Enabling noninvasive systemic delivery of the Kv1.3-blocking peptide HsTX1[R14A] via the buccal mucosa
Jin, L., Boyd, B. J., Larson, I. C., Pennington, M. W., Norton, R. S. & Nicolazzo, J. A., 1 Jul 2016, In: Journal of Pharmaceutical Sciences. 105, 7, p. 2173-2179 7 p.
Research output: Contribution to journal › Article › Research › peer-review

19 Citations (Scopus)
Buccal mucosal delivery of a potent peptide leads to therapeutically-relevant plasma concentrations for the treatment of autoimmune diseases
Jin, L., Boyd, B. J., White, P. J., Pennington, M. W., Norton, R. S. & Nicolazzo, J., 2015, In: Journal of Controlled Release. 199, p. 37 - 44 8 p.
Research output: Contribution to journal › Article › Research › peer-review

27 Citations (Scopus)